HB2048

Oklahoma HB2048 prohibits discrimination against 340B entities in prescription drug pricing and reimbursement.

Oklahoma HB2048, known as the 340B Nondiscrimination Act, aims to prevent discrimination against 340B entities in prescription drug pricing and reimbursement. The act prohibits entities from imposing different terms or conditions on 340B entities compared to non-340B entities. It also restricts manufacturers and distributors from interfering with pharmacies contracted with 340B entities. Enforcement of the act is overseen by the Attorney General and the Insurance Commissioner, who can impose penalties for violations.